Cargando…
Long-Term Safety and Efficacy of Fecal Microbiota Transplantation in the Treatment of Clostridium difficile Infection in Patients With and Without Inflammatory Bowel Disease: A Tertiary Care Center’s Experience
BACKGROUND: Clostridium difficile infection (CDI) carries a large burden on the national public health with its high morbidity and mortality rates. Patients with inflammatory bowel disease (IBD) are generally at higher risk of infection, recurrence and complications. Therefore, the need for more rel...
Autores principales: | Tabbaa, Obada M., Aboelsoud, Mohammed M., Mattar, Mark C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306107/ https://www.ncbi.nlm.nih.gov/pubmed/30627262 http://dx.doi.org/10.14740/gr1091 |
Ejemplares similares
-
Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
por: Hussam, Dina, et al.
Publicado: (2017) -
Patient Perspectives on Fecal Microbiota Transplantation for Clostridium Difficile Infection
por: Zellmer, Caroline, et al.
Publicado: (2016) -
Treatment of relapsing Clostridium difficile infection using fecal microbiota transplantation
por: Pathak, Rahul, et al.
Publicado: (2013) -
Fecal Microbiota Transplantation: Expanding Horizons for Clostridium difficile Infections and Beyond
por: Borody, Thomas J., et al.
Publicado: (2015) -
Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection
por: Dupont, Hebert, et al.
Publicado: (2017)